NASDAQ
No price data available for this timeframe.
Stoke Therapeutics, Inc. (STOK) has a current ratio of 5.28x as of Tuesday, May 26, 2026. This represents a 37.76% decrease compared to its 12-month average of 8.49x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.